Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$9.97 - $14.52 $19.9 Million - $29 Million
2,000,000 Added 400.0%
2,500,000 $35.5 Million
Q2 2023

Aug 11, 2023

BUY
$10.72 - $13.3 $5.36 Million - $6.65 Million
500,000 New
500,000 $6.28 Million
Q1 2020

May 14, 2020

BUY
$6.63 - $11.16 $3.32 Million - $5.58 Million
500,000 Added 100.0%
1,000,000 $9.24 Million
Q4 2018

Feb 11, 2019

SELL
$8.38 - $13.44 $4.19 Million - $6.72 Million
-500,000 Reduced 50.0%
500,000 $4.79 Million
Q3 2018

Nov 09, 2018

BUY
$11.6 - $16.54 $5.8 Million - $8.27 Million
500,000 Added 100.0%
1,000,000 $12.1 Million
Q2 2018

Aug 10, 2018

SELL
$13.13 - $17.09 $5.25 Million - $6.84 Million
-400,000 Reduced 44.44%
500,000 $7.81 Million
Q1 2018

May 10, 2018

SELL
$13.76 - $17.12 $6.88 Million - $8.56 Million
-500,000 Reduced 35.71%
900,000 $13.5 Million
Q4 2017

Feb 09, 2018

BUY
$12.51 - $16.24 $5 Million - $6.5 Million
400,000 Added 40.0%
1,400,000 $20.1 Million
Q3 2017

Nov 08, 2017

BUY
$11.74 - $15.78 $11.7 Million - $15.8 Million
1,000,000
1,000,000 $15.1 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.58B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.